Table 1.
Baseline demographic data and lesion characteristics by treatment group. Mean (SD) or n (%)
Stent | Control | P value | |
---|---|---|---|
Age (years) | 71.3 (5.3) | 69.8 (5.8) | 0.184 |
Sex | 0.540 | ||
Male | 23 | 23 | |
Female | 28 | 21 | |
ABI | 0.58 (.125) | 0.63 (.171) | 0.129 |
Walking distance (m) | 178 (87.3) | 210 (107.4) | 0.114 |
Duration of IC (months) | 30 (29.3) | 41 (48.3) | 0.179 |
Smoking | 0.125 | ||
Yes (n) | 7 | 11 | |
Former (n) | 27 | 32 | |
Never (n) | 12 | 5 | |
LDL (mmol/l) | 2.75 (1.1) | 2.55 (.9) | 0.374 |
B-glucose (mmol/l) | 7.0 (2.8) | 6.3 (2.1) | 0.207 |
Systolic BP (mmHg) | 155 (21.7) | 150 (20.7) | 0.282 |
Diastolic BP (mmHg) | 80 (11.3) | 79 (8.8) | 0.831 |
S-creatinine (µmol/l) | 84 (24.5) | 82 (21.9) | 0.653 |
Lesion length (mm) | 145 (91) | 103 (97) | 0.021 |
Occlusion (n) | 31 | 36 | 0.654 |
Stenosis (n) | 14 | 13 | NS |
Degree of stenosis (%) | 81.7 (16.3) | 91.5 (3.1) | 0.065 |
No crural vessels (n) | 2.5 (.6) | 2.3(.7) | 0.219 |
B = blood, P = plasma, S = serum, BP = blood pressure, IC = intermittent claudication, LDL = low-density protein, ABI = ankle–brachial index